Genomic and Expression Analysis of the 3q25-Q26 Amplification Unit Reveals TLOC1/SEC62 as a Probable Target Gene in Prostate Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-05-0165
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Gene Expression Profiling Reveals Overexpression of TSPAN13 in Prostate Cancer

International Journal of Oncology
Cancer ResearchOncology
1992English

Weighted Gene Co-Expression Network Analysis Identifies CCNA2 as a Treatment Target of Prostate Cancer Through Inhibiting Cell Cycle

Journal of Cancer
Oncology
2020English

A microRNA Cluster as a Target of Genomic Amplification in Malignant Lymphoma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Analysis of Tim-3 as a Therapeutic Target in Prostate Cancer

Tumor Biology
MedicineCancer Research
2017English

Genomic and Epigenomic Analysis of High-Risk Prostate Cancer Reveals Changes in Hydroxymethylation and TET1

Oncotarget
Oncology
2016English

Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy

American Journal of Pathology
Forensic MedicinePathology
2011English

Integrated Analysis of Expression and Genome Alteration Reveals Putative Amplified Target Genes in Esophageal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

Comprehensive Characterization of the DNA Amplification at 13q34 in Human Breast Cancer Reveals TFDP1 and CUL4A as Likely Candidate Target Genes

Breast Cancer Research
Cancer ResearchOncology
2009English

Analysis of Pten Expression in Prostate Cancer

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy